hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

AIDS drugs patent pool given green light, success rests on drug firms says Medecins Sans Frontieres

Get RSS feed of these results

All components of this story

Article
15 December 2009

'Patent pool' to boost AIDS drug access

Author: AFP

A global "patent pool" for AIDS drugs will be launched next year in a bid to slash…the cost of producing generic medicines for the developing world…the mechanism was given the green light at a board meeting in Geneva Monday...UNITAID will provide start-up funds…over the coming year, and has…held talks with…Gilead, Johnson and Johnson, Merck and Sequoia on signing up…Medecins Sans Frontieres welcomed "a decisive step to improve access to medicines in the developing world," but warned that success would depend on solid backing from drug firms…

Read the full post here

Article
+ Français - Hide

Author: AFP

Une "communauté de brevets" pour la production de médicaments à moindres coûts contre le sida va commencer à opérer à la mi-2010, a annoncé lundi soir la Facilité internationale d'achats de médicaments (Unitaid)... Cette création est le fruit de pourparlers avec les laboratoires pharmaceutiques comme Gilead, Tibotec (Johnson & Johnson), Merck et Sequoia, a précisé M. Douste-Blazy [président d'Unitaid]. L'annonce de la création de la communauté de brevets a été saluée par l'ONG Médecins sans frontières (MSF)... [mais le] "Patent pool sera jugé sur ses résultats pour les patients", a prévenu Mme Michelle Childs, directrice à MSF, en soulignant que son succès dépendra de l'engagement des laboratoires pharmaceutiques.

🚫Read the full post here